您使用提示模式 关闭

XDNA - Kelly CRISPR & Gene Editing Technology ETF (USD) (US48817R7061)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
ETF & Funds ceased circulation
 
(%)
US48817R7061
XDNA ISIN
交易所交易基金 (ETF)
基金类型
Kelly
提供商
-
每股资产净值
2022-01-12
成立日期
1 每年的次数
股息的支付
CEOJLS
CFI
XDNA
代码
Closed
Status
Equity
投资项目
Healthcare
部门
Global
地区分布
Strategic CRISPR & Gene Editing Technology Index
基准
0.78 %
总成本比率
Physical
复制方法
否
UCITS

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The Kelly CRISPR & Gene Editing Technology ETF seeks to replicate the price and yield performance of the Strategic CRISPR & Gene Editing Technology Index investing in a concentrated portfolio of companies that engage in CRISPR & gene editing technology activities

XDNA profile

The Kelly CRISPR & Gene Editing Technology ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Kelly fund’s base currency is USD and the share class was registered 12.01.2022 with unique ISIN - US48817R7061. Main exchange is NASDAQ and ticker symbol is XDNA. The total expense ratio is 0.78%. The Kelly CRISPR & Gene Editing Technology ETF (USD) pays dividends 1 time(s) per year.

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权